News
Many breast cancer patients use cannabis for symptom relief
Survey finds that physicians were not highly regarded as a source of information about cannabis use.
News
Success in closing racial survival gap in lung and breast cancer
Adopting internal changes to system processes can eliminate racial disparities in cancer survival while improving survival for for all patients....
News
SBRT on oligoprogressive lesions: Benefit in lung cancer
Stereotactic body radiation therapy proves to be beneficial for non–small cell lung cancer, but there was no benefit for breast cancer patients....
News
Now Takeda offers rebate if lung cancer drug fails to work
Brigatinib’s list price is $17,000 for a month’s treatment.
News
Pfizer offers refund if drug ‘doesn’t work’
Although Pfizer claims that its pilot program is a first in the industry, there have been others that are similar.
News
Tramadol linked to higher risk of mortality, compared with codeine
Tramadol is widely used for noncancer pain but, as compared with codeine, it was associated with a higher risk for adverse outcomes, including...
News
No advantages to using ADM in implant-based breast reconstruction
“We feel that women considering implant-based reconstructions for breast cancer should be informed about the lack of evidence supporting its...
News
Case report: Lung cancer shrinks in patient using CBD oil
“We are unable to conclusively confirm that the tumour regression is due to the patient taking ‘CBD oil,’ ” the authors of the case report wrote...
News
Failure to communicate ‘doc-to-doc’ blamed for patient’s death
The surgical oncologist apparently did not clearly communicate the situation to the rest of the clinicians involved in the patient’s care.
News
‘Regionalized’ care tied to better survival in tough cancer
Gastric cancer patients treated within an integrated health care system had better outcomes, fewer complications, and increased overall survival,...
News
FDA approval for tisotumab vedotin in advanced cervical cancer
The mainstay of therapy in this setting is monotherapy with chemotherapy, but the benefit-risk profiles are poor, and overall response rates are...
News
Severe skin reactions with enfortumab vedotin
Enfortumab vedotin is a first-in-class agent directed against cell adhesion molecule nectin-4 and is highly expressed in bladder cancer.
News
Oncologists’ income and net worth rise despite pandemic
Oncologists’ average annual income rose from $377,000 in 2020 to $403,000 this year.